1. Sekhon BS, Saluja V. Biosimilars: an overview. Biosimilars. 2011;1:1–11.
2. European Medicines Agency. Guideline on similar biological medicinal products. Report no.: CHMP/437/04 rev 1. London: European Medicines Agency; 2014.
3. US Food and Drug Administration. Guidance for industry: scientific considerations in demonstrating biosimilarity to a reference product. Rockville: US Food and Drug Administration; 2015.
4. Felix T, Johansson TT, Colliatie JA, Goldberg MR, Fox AR. Biologic product identification and US pharmacovigilance in the biosimilars era. Nat Biotechnol. 2014;32(2):128–30.
5. US Food and Drug Administration. Guidance for industry: biosimilars: questions and answers regarding implementation of the Biologics Price Competition and Innovation Act of 2009. Rockville: US Food and Drug Administration; 2015.